Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Retained Earnings of $2.3 billion for Q4 2025, up 272.94% year-over-year from $628.9 million in Q4 2024, and up 272.94% quarter-over-quarter from -$1.4 billion in Q4 2024.
Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $2.3 billion for Q4 2025.
- In Q4 2025, Retained Earnings rose 272.94% year-over-year to $2.3 billion; the TTM figure through Dec 2025 stood at $2.3 billion (up 272.94% YoY), while the FY2025 annual figure was $2.3 billion, up 272.94% from the prior year.
- Retained Earnings for Q4 2025 stood at $2.3 billion, up from -$1.4 billion in the prior quarter.
- The five-year high for Retained Earnings was $2.3 billion in Q4 2025, with the low at -$311.4 billion in Q1 2022.
- The 5-year median for Retained Earnings is -$247.4 million (2021), against an average of -$22.4 billion.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 146877.19% in 2022, then soared 272.94% in 2025.
- Curaleaf Holdings' Retained Earnings stood at -$489.5 million in 2021, then advanced by 19.9% to -$392.1 million in 2022, then soared by 96.97% to -$11.9 million in 2023, then slumped by 11320.41% to -$1.4 billion in 2024, then jumped by 272.94% to $2.3 billion in 2025.
- Business Quant data shows CURLF's Retained Earnings at $2.3 billion in Q4 2025, -$1.4 billion in Q4 2024, and -$8.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 2.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Dec 31, 2024 | -1.36 Bn |
| Sep 30, 2024 | -8.05 Mn |
| Jun 30, 2024 | -15.15 Mn |
| Dec 31, 2023 | -11.88 Mn |
| Sep 30, 2023 | -1.08 Bn |
| Jun 30, 2023 | -13.86 Mn |
| Sep 30, 2022 | -392.06 Mn |
| Jun 30, 2022 | -338.71 Mn |
| Mar 31, 2022 | -311.38 Bn |
| Dec 31, 2021 | -489.46 Mn |
| Sep 30, 2021 | -275.61 Mn |
| Jun 30, 2021 | -219.10 Mn |
| Mar 31, 2021 | -211.86 Mn |
| Dec 31, 2020 | -190.07 Mn |
| Sep 30, 2020 | -159.37 Mn |
| Dec 31, 2019 | -132.91 Mn |